Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jinsaizeng dose-comparison study in children with idiopathic short stature
ChiCTR2400087245Phase 4Not yet recruiting
- Sponsor
- Children's Hospital, Zhejiang University School of Medicine
- Start
- May 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of genotropin miniquick in Idiopathic Short Stature (ISS) (3 arms), sponsored by Children's Hospital, Zhejiang University School of Medicine. Primary endpoint: Change in height standard deviation score at Week 52. Planned start May 2024; status: not yet recruiting.
02
Drugs
genotropin miniquick
03
Conditions
Idiopathic Short Stature (ISS)
Beyond the preview
Go deeper on ChiCTR2400087245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400087245.